new_0222_0353|TNYA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0353|TNYA|Long Name|1|1|Tenaya Therapeutics Inc Total Current Assets (Quarterly) (USD)|Tenaya Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Tenaya Therapeutics Inc Inventories (Quarterly) (USD)|Tenaya Therapeutics Inc Net PP&E (Quarterly) (USD)|Tenaya Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Tenaya Therapeutics Inc Total Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Deposits (Quarterly) (USD)|Tenaya Therapeutics Inc Book Value (Quarterly) (USD)|Tenaya Therapeutics Inc Retained Earnings (Quarterly) (USD)|Tenaya Therapeutics Inc Treasury Stock (Quarterly) (USD)|Tenaya Therapeutics Inc EV to Revenues|Tenaya Therapeutics Inc EV to Earnings|Tenaya Therapeutics Inc EV to Free Cash Flow|Tenaya Therapeutics Inc EV to Assets (Quarterly)|Tenaya Therapeutics Inc PS Ratio|Tenaya Therapeutics Inc PE Ratio|Tenaya Therapeutics Inc Price to Book Value|Tenaya Therapeutics Inc PEG Ratio|Tenaya Therapeutics Inc Debt to Equity Ratio|Tenaya Therapeutics Inc Dividend Yield|Tenaya Therapeutics Inc Shareholder Yield (TTM)|Tenaya Therapeutics Inc Percent of Shares Outstanding Short|Tenaya Therapeutics Inc Total Receivables (Quarterly) (USD)|Tenaya Therapeutics Inc Total Payables (Quarterly) (USD)|Tenaya Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Tenaya Therapeutics Inc Return on Invested Capital|Tenaya Therapeutics Inc Quality Ratio Score|Tenaya Therapeutics Inc Momentum Score|Tenaya Therapeutics Inc Beta (1Y)|Tenaya Therapeutics Inc Sustainable Growth Rate (TTM)|Tenaya Therapeutics Inc Institutional Investor Ownership Percentage|Tenaya Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Tenaya Therapeutics Inc Total Employees (Annual)|Tenaya Therapeutics Inc EPS Diluted (Quarterly) (USD)|Tenaya Therapeutics Inc Shares Outstanding|Tenaya Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Tenaya Therapeutics Inc Ordinary Shares Number (Quarterly)|Tenaya Therapeutics Inc Payout Ratio|Tenaya Therapeutics Inc Quick Ratio (Quarterly)|Tenaya Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Tenaya Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Tenaya Therapeutics Inc Effective Tax Rate (TTM)|Tenaya Therapeutics Inc Return on Equity|Tenaya Therapeutics Inc Net Income (TTM) (USD)|Tenaya Therapeutics Inc Revenue (TTM) (USD)|Tenaya Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Tenaya Therapeutics Inc Revenue (Quarterly) (USD)|Tenaya Therapeutics Inc Gross Profit (Quarterly) (USD)|Tenaya Therapeutics Inc SG&A Expense (Quarterly) (USD)|Tenaya Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Tenaya Therapeutics Inc Net Income (Quarterly) (USD)|Tenaya Therapeutics Inc Net Interest Income (Quarterly) (USD)|Tenaya Therapeutics Inc Price (USD)|Tenaya Therapeutics Inc Total Return Price (USD)|Tenaya Therapeutics Inc Enterprise Value (USD)|Tenaya Therapeutics Inc 30-Day Average Daily Volume|Tenaya Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0353|TNYA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0353|TNYA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0353|TNYA||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44117647059|0|0|0|1.44086021505|0|0|1.44117647059|0|15.4166666667|0|91|91|0|0|0|0|0|31|91.3333333333|92|91.3333333333|16.3333333333|91.4|91|0|0|91.3333333333|91.4|91|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44117647059|1.44117647059|1.44117647059|1.43925233645|0
new_0222_0353|TNYA||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|136|0|0|0|93|0|0|136|0|12|0|3|3|0|0|0|0|0|1|6|1|6|6|5|3|0|0|6|5|3|0|3|0|0|0|0|6|6|6|6|136|136|136|107|0
new_0222_0353|TNYA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0353|TNYA|202003|202003|202003||||||||||||||||||||||||||||||||||27.2001||-0.3328||||||-0.3328|||||||||1.969|-9.051|-9.051|0.057|||||
new_0222_0353|TNYA|202006|202006|202006||||||||||||||||||||||||||||||||||27.2001||-0.321||0||||-0.321|0||||||||1.914|-8.731|-8.731|0.018|||||
new_0222_0353|TNYA|202009|202009|202009||||||||||||||||||||||||||||||||||27.2001||-0.3785||-0.001||||-0.3785|0.001||||||||1.972|-10.295|-10.295|0.007|||||
new_0222_0353|TNYA|202012|202012|202012|129.964|128.535||17.185||229.476|5.041|224.435||-81.315|-82.812|||||||||||||||1.017|0|||||||27.2001||-0.3793||0|37.3247|||-0.3793|0|0||-38.395|||||1.958|-10.318|-10.318|0.005|||||
new_0222_0353|TNYA|202103|202103|202103|129.75|128.439||25.682||253.7|5.91|247.79||-93.943|-95.91|||||||||||||||2.092|0|||||||27.2001||-0.48|||37.3247|||-0.48||0||-42.442|||||3.515|-13.098|-13.098|0.009|||||
new_0222_0353|TNYA|202106|202106|202106|113.222|111.886||37.225||265.431|9.8|255.631||-108.536|-111.12|||||||||||||||5.02|0|||||||37.3247|85|-0.4075||-0.01|37.3247|||-0.4075|0.01|0||-48.921|||||4.331|-15.21|-15.21|0.009|||||
new_0222_0353|TNYA|202107|202106|202106|||||||||||||||-7.7269|||||||0||0|||||||||36.7557||||39.3247||||||||||||||||||15.35|15.35|491.7481||
new_0222_0353|TNYA|202108|202106|202106|||||||||||||||-11.3274|||||||0||0.3694|||||||||42.7163||||41.1247||||||||||||||||||20.25|20.25|720.8892||
new_0222_0353|TNYA|202109|202109|202109|284.822|280.465||42.897||28.095|13.692|14.403||303.699|-129.382||||-7.5648||||2.8069|||0||2.2361||6.171|0.004|||||||26.8957|100|-0.68|41.2804|-0.003|41.2804|||-0.68|-188.602|0||-56.888|||||5.356|-18.262|-18.262|0.023|20.65|20.65|571.9753|247156.9667|
new_0222_0353|TNYA|202110|202109|202109|||||||||||||||-10.3274||||3.4946|||0||2.6673|||||||||||||||||||||||||||||||25.71|25.71|780.8541|104866.1333|
new_0222_0353|TNYA|202111|202109|202109|||||||||||||||-7.0191||||2.671|||0||3.6326|||||||||||||41.2812||||||||||||||||||19.65|19.65|530.7106|98038.9333|
new_0222_0353|TNYA|202112|202112|202112|||||||||||||||-6.6369||||2.5758|||0||4.8314|||||||||||||||||||||||||||||||18.95|18.95|501.8137|112573.4667|
new_0222_0353|TNYA|202201|202112|202112|||||||||||||||-2.7987||||1.6203|||0||6.4679|||||||||||||||||||||||||||||||11.92|11.92|211.6069|178200.9333|
new_0222_0353|TNYA|202202|202112|202112|||||||||||||||-4.4475||||2.0308|||0|||||||||||||||||||||||||||||||||14.94|14.94|336.2761|182270.1667|